During the past decade, Fabio Fernandes conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fabio Fernandes" #1 collaborator was "Fleury" with 1 trials as a collaborator and "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fabio Fernandes" are "Amyloid Neuropathies" (1 trials), "Autonomic Nervous System Disease" (1 trials), "Chagas Disease" (1 trials) and "Colchicine Resistance" (1 trials). Many other conditions were trialed in "Fabio Fernandes" in a lesser frequency.

Most popular intervention types in "Fabio Fernandes" are "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Colchicine 0.5 MG twice day for one year" (1 trials), "Head-Up Tilt table test" (1 trials), "Heart Rate Variability" (1 trials) and "Placebo Oral Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fabio Fernandes" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fabio Fernandes". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fabio Fernandes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fabio Fernandes, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".